1. Home
  2. BODI vs PDSB Comparison

BODI vs PDSB Comparison

Compare BODI & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Beachbody Company Inc.

BODI

The Beachbody Company Inc.

HOLD

Current Price

$10.18

Market Cap

75.4M

Sector

Industrials

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$1.05

Market Cap

62.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BODI
PDSB
Founded
1998
2005
Country
United States
United States
Employees
270
10
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.4M
62.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
BODI
PDSB
Price
$10.18
$1.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$15.00
$9.00
AVG Volume (30 Days)
66.3K
1.1M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$20.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.53
$0.51
52 Week High
$16.87
$1.90

Technical Indicators

Market Signals
Indicator
BODI
PDSB
Relative Strength Index (RSI) 39.53 46.64
Support Level $9.54 $0.88
Resistance Level $11.11 $1.12
Average True Range (ATR) 0.92 0.14
MACD -0.02 -0.01
Stochastic Oscillator 33.91 10.42

Price Performance

Historical Comparison
BODI
PDSB

About BODI The Beachbody Company Inc.

The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: